Families deserve explanations that neither exaggerate a statistical comparison nor use its limits to dismiss disability. CDC's March 3, 2017 report established a birth-defect reference from Massachusetts, North Carolina and metropolitan Atlanta: 747 infants and fetuses, or 2.86 per 1,000 live births. Those figures describe a population baseline, not the worth or future of any child. [mm6608a4][mm6503e3]

The report contrasted that baseline with pregnancies involving evidence of possible Zika infection. Selection and closer follow-up complicated the comparison. Geographic limits, possible earlier travel infections, missed congenital deafness and unavailable comparisons for other defects also mattered. Unspecified flavivirus infections could dilute the registry proportion; uncertainty was not simply a reason to assume the association was exaggerated. [mm6608a4][mm6503e3]

CDC's January 2016 guidance supplies a concrete reason to speak carefully about laboratory labels. Cross-reacting antibodies could yield false positives, and neutralization testing could help distinguish related viruses while still leaving some results inconclusive. This superseded guidance is historical context, not a recommendation about anyone's care. A possible infection, a laboratory finding and a congenital abnormality are different kinds of information. [mm6608a4][mm6503e3]

For an interfaith conversation that welcomes nonreligious participants, the ethical task is to preserve both truthfulness and dignity. That is an editorial application, not a finding of the studies or a claim that religious traditions agree. A useful conversation can acknowledge serious harms, explain the limits of a comparison and refuse to make a family's claim to support depend on statistical certainty. [mm6608a4][mm6503e3]

Source documents

  1. Baseline Prevalence of Birth Defects Associated with Congenital Zika Virus Infection — Massachusetts, North Carolina, and Atlanta, Georgia, 2013–2014https://www.cdc.gov/mmwr/volumes/66/wr/mm6608a4.htm
  2. Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection — United States, 2016https://www.cdc.gov/mmwr/volumes/65/wr/mm6503e3.htm